http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease.
Giesen, N. (First author)DKFZ* ; Schwarzbich, M.-A. ; Dischinger, K. ; Becker, N.DKFZ* ; Hummel, M.DKFZ* ; Benner, A.DKFZ* ; Radujkovic, A. ; Müller-Tidow, C. ; Dreger, P. ; Luft, T.
2020
Ovid
[s.l.]
This record in other databases: 
Please use a persistent id in citations: doi:10.1097/TP.0000000000003108
Abstract: CXCL9 predicts Severity at Onset of Chronic Graft-Versus-Host Disease.
Note: #EA:A360#2020 Nov;104(11):2354-2359
Contributing Institute(s):
- KKE Mol. Hämatologie/Onkologie (A360)
- C060 Biostatistik (C060)
Research Program(s):
- 311 - Signalling pathways, cell and tumor biology (POF3-311) (POF3-311)
Appears in the scientific report
2020
Database coverage:
; Allianz-Lizenz ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz

; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection